Financials
- Market Capitalization 11.35 B
- Employee 3 000
- Founded 1976
- CEO Charles R. Kummeth
- Website www.bio-techne.com
- Headquarter Minnesota, United States
- FIGI BBG000C15114
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
60.91
ratio cours/chiffre d'affaires
9.13
Dividende par action
0.32
Rendement du dividende (%)
0.45
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 818 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 85.37 USD | -3.63% | -1.32% | -0.22% | +118.34% | 12.06 B USD | ||
| 828 | HALO Halozyme Therapeutics, Inc. - Common Stock | 105.64 USD | -1.20% | -2.58% | +27.15% | +58.14% | 11.99 B USD | ||
| 870 | SMMT Summit Therapeutics Inc. - Common Stock | 13.79 USD | -3.77% | +5.11% | +9.36% | -30.56% | 11.00 B USD | ||
| 892 | AXSM Axsome Therapeutics, Inc. - Common Stock | 201.10 USD | -2.51% | -3.75% | -14.76% | +54.45% | 10.53 B USD |